Literature DB >> 24094033

The interference of monoclonal antibodies with laboratory diagnosis: clinical and diagnostic implications.

Barbara E Ostrov1, Daniel Amsterdam.   

Abstract

Diagnostic test interference is due to the presence of material that falsely changes an analytic test result. The development of monoclonal antibodies is discussed with focus on their extensive use as both therapeutic and diagnostic agents. In this review the interference of monoclonal antibodies with laboratory test methods and the potential impact on clinical care is addressed. Recognition of the types of interference, endogenous and exogenous, and the varied mechanisms by which monoclonal antibodies may cause interference are discussed in this report. Review of the literature identifies cases which exemplify the issues facing laboratorians and clinicians and describe the impact on patients. Approaches to reducing and eliminating sources of interference are also addressed. Education of ordering clinicians concerning the possibility of interference in at-risk patients is key in limiting the impact on care. Laboratorians and medical practitioners should be cognizant of the risk of interference to avoid incorrect management of patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24094033     DOI: 10.3109/08820139.2013.837918

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  3 in total

Review 1.  Therapeutic monoclonal antibodies and clinical laboratory tests: When, why, and what is expected?

Authors:  Zhanhu Zhang; Wenjie Hu; Linlin Li; Hongxia Ding; Haibo Li
Journal:  J Clin Lab Anal       Date:  2017-08-15       Impact factor: 2.352

Review 2.  Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma.

Authors:  Philippe Moreau; Niels W C J van de Donk; Jesus San Miguel; Henk Lokhorst; Hareth Nahi; Dina Ben-Yehuda; Michele Cavo; Gordon Cook; Michel Delforge; Hermann Einsele; Sonja Zweegman; Heinz Ludwig; Christoph Driessen; Antonio Palumbo; Thierry Facon; Torben Plesner; Meletios Dimopoulos; Pia Sondergeld; Pieter Sonneveld; María-Victoria Mateos
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

3. 

Authors:  Imene Ben Jdidia; Kaouther Zribi; Meriam Boubaker; Amira Brahem; Mouna Sayadi; Marwa Tlijani; Zahra Saidani; Amani Cherif
Journal:  Can J Hosp Pharm       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.